My primary research interests concern the mechanisms underlying the heterogeneity of presentations and outcomes in psychosis. I am also working on the Psychosis Risk Outcomes Network (ProNET) study, which aims to identify multimodal biomarkers spanning psychopathology, cognition, MRI, EEG, genetics, and natural language data to predict individual clinical trajectories and outcomes in people at clinical-high risk of psychosis.
